Orlistat influence on clinical, hormonal and metabolic parameters of obese patients with high risk of type 2 diabetes and cardiovascular diseases

被引：0

作者：

Boutrova, S ^{[1
]}

Ershova, E ^{[1
]}

Ilyin, A ^{[1
]}

Kolesnikova, G ^{[1
]}

机构：

[1] Russian Endocrinol Res Ctr, Moscow, Russia

来源：

INTERNATIONAL JOURNAL OF OBESITY | 2004年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S115 / S115

页数：1

共 50 条

[1] Orlistat (xenical®) reduces cardiovascular disease risk factors in obese patients with type 2 diabetes
Hollander, P
Lucas, C
Segal, KR
DIABETOLOGIA, 1998, 41 : A126 - A126
[2] Effects of weight reduction with orlistat on cardiovascular risk in obese hyertensive patients with type 2 diabetes
Uehara, MH
Peres, RB
Ferreira, SRG
Zanella, MT
HYPERTENSION, 2001, 37 (03) : 1042 - 1042
[3] The ORListat and cardiovascular risk profile in patients with metabolic syndrome and type 2 Diabetes (ORLICARDIA) study
Didangelos, TP
Thanopoulou, AK
Bousboulas, SH
Sambanis, CL
Athyros, VG
Spanou, EA
Dimitriou, KC
Pappas, SI
Karamanos, BG
Karamitsos, DT
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1393 - 1401
[4] Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetes
Oh, S
Park, CY
Woo, JT
Kim, YS
Son, HY
Lee, HC
DIABETES, 2004, 53 : A595 - A595
[5] Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetes
Kim, YS
Park, CY
Son, HY
Lee, HC
OBESITY RESEARCH, 2004, 12 : A39 - A39
[6] Orlistat enhances weight loss and improves cardiovascular risk factors in overweight and obese patients with Type 2 diabetes
Guy-Grand, B
Caterson, I
Lindgärde, F
Shi, YE
Broom, L
DIABETOLOGIA, 2004, 47 : A250 - A250
[7] Improvement of glycemic control with orlistat in overweight and obese patients with metabolic syndrome and type 2 diabetes
Hollander, P
Rissanen, A
Rabbia, M
Hauptman, J
Boldrin, M
DIABETES, 2003, 52 : A557 - A557
[8] Orlistat promotes glucemia control and other cardiovascular risk factors lowering in obese patients with type 2 diabetes. Randomised clinical trial.
Hawkins, F
Duran, S
Vilardell, E
Soriguer, F
Cabezas, J
Escobar, F
Miralles, JM
Faure, E
Bellido, D
Herrera, JL
Serrano-Rios, M
Tebar, J
Freijane, J
Armero, F
DIABETOLOGIA, 2000, 43 : A171 - A171
[9] High Risk Factors of Cardiovascular Diseases in Type 2 Diabetes
Srilatha, B.
JOURNAL OF DIABETES & METABOLISM, 2011, 2 (09)
[10] Influence of change of lifestyle and dietary rules in obese patients with type 2 diabetes on cardiovascular risk
Juliard, Jean-Michel
SANG THROMBOSE VAISSEAUX, 2013, 25 (04): : 211 - 213

← 1 2 3 4 5 →